Splash Beverage (SBEV) 10-Q 13 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 13, 2020
Document And Entity Information
Entity Registrant Name	SPLASH BEVERAGE GROUP, INC.
Entity Central Index Key	0001553788
Document Type	10-Q
Document Period End Date	Sep. 30, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Entity Interactive Data Current	Yes
Entity File Number	000-55114
Entity Incorporation, State or Country Code	CO
Entity Common Stock, Shares Outstanding		73,197,290
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets
Cash	$ 725,811	$ 42,639
Funds in Escrow	1,000,000
Accounts Receivable, net	547,498	11,430
Prepaid Expenses	219,575	5,449
Inventory	627,386	304,012
Other receivables	18,887	7,132
Total current assets	3,139,157	370,662
Non-current assets:
Deposit	39,089	34,915
Goodwill	9,448,852
Investment in Salt Tequila USA, LLC	250,000
Right of use asset, net	100,667	162,008
Property and equipment, net	59,172	37,729
Total non-current assets	9,897,780	234,652
Total Assets	13,036,937	605,314
Current Liabilities
Accounts payable and accrued expenses	1,080,953	703,885
Right of use liability - current	70,297	81,502
Due to related parties	469,904	429,432
Bridge loan payable, net		2,200,000
Related party notes payable		1,505,100
Convertible Loan Payable	100,000	2,202,664
Notes payable, current portion	703,565	875,000
Royalty payable		39,000
Revenue financing arrangements		45,467
Shareholder advances	1,103,773	46,250
Accrued interest payable	421,952	1,604,498
Accrued interest payable - related parties		546,362
Total Current liabilities	3,950,444	10,279,160
Long-term Liabilities:
Right of use liability - noncurrent	32,940	82,238
Total Long-term liabilities	32,940	82,238
Total liabilities	3,950,596	10,361,398
Common stock, (mezzanine shares) 12,605,283 shares, contingently convertible to notes payable at September 30, 2020	9,248,720
Deficiency in stockholders' equity:
Common Stock, $0.001 par, 150,000,000 shares authorized, 60,574,873 and 44,021,382 shares issued 60,574,873 and 43,885,090 outstanding, at September 30, 2020 and December 31, 2019, respectively	60,575	44,021
Additional paid-in capital	38,763,100	22,095,403
Treasury Stock, $0.001 par, 100,000 shares at cost		(50,000)
Accumulated deficit	(39,018,841)	(31,845,508)
Total deficiency in stockholders' equity	(195,166)	(9,756,084)
Total liabilities mezzanine shares and deficiency in stockholders' equity	$ 13,036,937	$ 605,314

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Contingently convertible to notes payable shares	12,605,283
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	60,574,873	44,021,382
Common stock, shares outstanding	60,574,873	43,885,090
Treasury Stock cost	100,000
Treasury Stock par value	0.001

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Net revenues	$ 1,009,615		$ 1,733,926	$ 47,086
Cost of goods sold	(570,979)	(13,947)	(965,966)	(88,365)
Gross margin	438,636	(13,947)	767,960	(41,279)
Operating expenses:
Contracted services	1,954,165	450,753	2,377,843	881,523
Salaries and wages	442,441	171,357	1,049,130	583,619
Other general and administrative	298,277	205,300	1,487,948	507,143
Sales and marketing	38,551	20,247	85,793	52,899
Total operating expenses	2,733,434	847,657	5,000,714	2,025,184
Loss from operations	(2,294,798)	(861,604)	(4,232,754)	(2,066,463)
Other income/ (expense):
Other Income	16,351	9,587	16,351	9,587
Interest income	16,354		32,710
Interest expense	(23,110)	(215,229)	(1,958,601)	(635,753)
Gain from debt extinguishment	1,521		36,483
Total other income (expense)	11,116	(205,642)	(1,873,057)	(626,166)
Net loss	$ (2,283,682)	$ (1,067,246)	$ (6,105,811)	$ (2,692,629)
Net loss per share (basic and diluted)	$ (0.04)	$ (0.03)	$ (0.11)	$ (0.07)
Weighted average number of common shares outstanding	58,397,694	40,570,619	53,108,031	41,228,247

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Deficiency in Stockholders' Equityn (Unaudited) - USD ($)	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance at Dec. 31, 2018	$ 40,165	$ (100,000)	$ 18,938,480	$ (26,709,776)	$ (7,831,132)
Beginning Balance, in Shares at Dec. 31, 2018	40,165,002	272,585
Issuance of Common stock for cash	$ 27		19,973		20,000
Issuance of Common stock for cash, in Shares	27,258
Issuance of Common stock for services	$ 1		999		1,000
Issuance of Common stock for services, in Shares	1,363
Net loss				(703,624)	(703,624)
Ending Balance at Mar. 31, 2019	$ 40,193	$ (100,000)	18,959,452	(27,413,400)	(8,513,755)
Ending Balance, in Shares at Mar. 31, 2019	40,193,623	272,585
Issuance of Common stock for cash	$ 484		354,516		355,000
Issuance of Common stock for cash, in Shares	483,837
Net loss				(921,520)	(921,520)
Ending Balance at Jun. 30, 2019	$ 40,677	$ (100,000)	19,313,968	(28,334,920)	(9,080,275)
Ending Balance, in Shares at Jun. 30, 2019	40,677,460	272,585
Issuance of Common stock for cash	$ 716		524,284		525,000
Issuance of Common stock for cash, in Shares	715,534
Issuance of Common stock for services	$ 191		139,809		140,000
Issuance of Common stock for services, in Shares	190,809
Issuance of Common stock from treasury		$ 50,000	49,900		99,900
Issuance of Common stock from treasury, in Shares		(136,292)
Net loss				(973,546)	(973,546)
Ending Balance at Sep. 30, 2019	$ 41,584	$ (50,000)	20,027,962	(29,308,466)	(9,288,921)
Ending Balance, in Shares at Sep. 30, 2019	41,583,803	136,293
Beginning Balance at Dec. 31, 2019	$ 44,021	$ (50,000)	22,095,403	(31,845,506)	(9,756,084)
Beginning Balance, in Shares at Dec. 31, 2019	44,021,389	136,293
Issuance of common stock for convertible debt			145,579		145,579
Issuance of common stock for convertible debt, in Shares
Incremental beneficial conversion for preferred A			240,770	(240,770)
Incremental beneficial conversion for preferred A, in Shares
Issuance of warrants on convertible instruments			2,486,706	(828,903)	1,657,803
Issuance of warrants on convertible instruments, in Shares
Issuance of Common stock for services	$ 818	$ 50,000	549,182		600,000
Issuance of Common stock for services, in Shares	817,753	(136,293)
Issuance of common stock for acquisition	$ 11,913		9,161,251		9,173,164
Issuance of common stock for acquisition, in Shares	11,913,200
Net loss				(3,446,630)	(3,446,630)
Ending Balance at Mar. 31, 2020	$ 56,752		34,678,891	(36,361,809)	(1,626,167)
Ending Balance, in Shares at Mar. 31, 2020	56,752,342
Issuance of warrants			77,434		77,434
Issuance of Common stock for cash	$ 250		142,316		142,566
Issuance of Common stock for cash, in Shares	249,912
Net loss				(373,350)	(373,350)
Ending Balance at Jun. 30, 2020	$ 57,002		34,898,641	(36,735,159)	(1,779,517)
Ending Balance, in Shares at Jun. 30, 2020	57,002,254
Issuance of warrants			438,431		1,236,254
Issuance of options	$ 181		(181)		0
Issuance of options, in shares	180,936
Issuance of Common stock for cash	$ 2,700		1,697,621		902,498
Issuance of Common stock for cash, in Shares	2,699,738
Issuance of Common stock for services	$ 692		1,728,588		1,729,280
Issuance of Common stock for services, in Shares	691,945
Net loss				(2,283,682)	(2,283,682)
Ending Balance at Sep. 30, 2020	$ 60,575		$ 38,763,100	$ (39,018,841)	$ (195,166)
Ending Balance, in Shares at Sep. 30, 2020	60,574,873

Condensed Consolidated Statem_3

Condensed Consolidated Statement Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows From Operating Activities:
Net loss	$ (6,105,811)	$ (2,692,629)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	26,339	7,088
Amortization of ROU Asset	61,341
Gain from debt extinguishment	(36,483)
Non-cash interest expense	590,283
Share-based compensation	2,329,280	532,276
Changes in working capital items:
Accounts receivable	(243,369)	(11,510)
Inventory	(269,172)	(79,969)
Prepaid expenses and other current assets	(206,994)	(21,523)
Deposits	(4,174)	(1,013)
Accounts payable and accrued expenses	(474,940)	(224,709)
Royalty payable	(39,000)	(21,062)
Accrued Interest payable	61,530	603,326
Net cash used in operating activities	(4,311,170)	(1,909,725)
Cash Flows From Investing Activities:
Capital expenditures	(9,693)	(9,942)
Investment in Salt Tequila USA, LLC	(150,000)
Net cash acquired in merger	72,442
Net cash used in investing activities	(87,251)	(9,942)
Cash Flows From Financing Activities:
Proceeds from issuance of Common stock	3,574,002	900,000
Funds placed in Escrow	(1,000,000)
Repayment of shareholder advance
Cash advance from shareholder	1,097,995
Proceeds from issuance of debt	1,470,099	130,000
Principal repayment of debt		(18,009)
Reduction of ROU Liability	(60,502)
Net cash provided by financing activities	5,081,594	1,011,991
Net Change in Cash and Cash Equivalents	683,172	(907,676)
Cash, beginning of year	42,639	938,040
Cash, end of period	725,811	30,364
Supplemental Disclosure of Cash Flow Information:
Cash paid for Interest
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Notes payable and accrued interest converted to common stock (12,605,283 shares)
Liability issued for investment in SALT Tequila USA, LLC	$ 9,248,720

Condensed Consolidated Statem_4

Condensed Consolidated Statement Cash Flows (Parenthetical)	9 Months Ended
	Sep. 30, 2020shares
Statements Of Cash Flows
Number of common stock converted	12,605,283

Business Organization and Natur

Business Organization and Nature of Operations	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Organization and Nature of Operations	Note 1 – Business Organization and Nature of Operations Splash Beverage Group (“SBG”), f/k/a Canfield Medical Supply, Inc. (the “CMS”), was incorporated in the State of Ohio on September 3, 1992, and changed domicile to Colorado on April 18, 2012. CMS is in the business of home health services, primarily the selling of durable medical equipment and medical supplies to the public, nursing homes, hospitals and other end users. On December 31, 2019, CMS entered into an Agreement and Plan of Merger (the “Merger Agreement”) with SBG Acquisition Inc. (“Merger Sub”), a Nevada Corporation wholly-owned by CMS, and Splash Beverage Group, Inc. a Nevada corporation (“Splash”) pursuant to which Merger Sub merged with and into Splash (the “Merger”) with Splash as the surviving company and a wholly-owned subsidiary of CMS. The Merger was consummated on March 31, 2020. As the owners and management of Splash have voting and operating control of CMS following the Merger, the Merger transaction was accounted for as a reverse acquisition (that is with Splash as the acquiring entity), followed by a recapitalization. As part of the recapitalization, previously issued shares of SBG preferred stock have been reflected as shares of common stock that were received in the Merger. These common shares have been retrospectively presented as outstanding for all periods. Splash specializes in the manufacturing, distribution, and sales & marketing of various beverages across multiple channels. Splash operates in both the non-alcoholic and alcoholic beverage segments. Additionally, Splash operates its own vertically integrated B-to-B and B-to-C E-commerce distribution platform called Qplash, further expanding its distribution abilities and visibility. On July 2, 2020, CMS received a Certificate of Good Standing from the State of Colorado. This certificate allowed us to change our name from Canfield Medical Supply, Inc. to Splash Beverage Group, Inc. a Colorado company. On July 31, 2020, we received approval from FINRA to change the Company’s name from Canfield Medical Supply, Inc. to Splash Beverage Group, Inc. Our new ticker symbol is SBEV.

Going Concern

Going Concern	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going concern	Note 3 – Going Concern The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Our business operations have not yet generated significant revenues, and we have sustained net losses of approximately $6.1 million during the nine months ended September 30, 2020 and have an accumulated deficit of approximately $39.0 million at September 30, 2020. In addition, we have current liabilities in excess of current assets of approximately $0.8 million at September 30, 2020. Further, we are in default on approximately $0.9 million of indebtedness, including accrued interest. Our ability to continue as a going concern in the foreseeable future is dependent upon our ability to generate revenues and obtain sufficient long-term financing to meet current and future obligations and deploy such to produce profitable operating results. Management has evaluated these conditions and plans to raise capital as needed and to generate revenues to satisfy our capital needs. No assurance can be given that we will be successful in these efforts. These factors, among others, raise substantial doubt about our ability to continue as a going concern for a reasonable period of time. These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

Notes Payable, Related Party No

Notes Payable, Related Party Notes Payable, Convertible Bridge Loans Payable, Revenue Financing Arrangements	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Notes Payable, Related Party Notes Payable, Convertible Bridge Loans Payable, Revenue Financing Arrangements and Bridge Loan Payable	Note 4 – Notes Payable, Related Party Notes Payable, Convertible Bridge Loans Payable, Revenue Financing Arrangements and Bridge Loan Payable Notes payable are generally nonrecourse and secured by all Company owned assets. Interest September 30, December 31, Notes Payable In October 2013, we entered into a short-term loan agreement with an entity in the amount of $25,000. The note matured and in March 2020 the full outstanding principal balance of $25,000 and unpaid accrued interest of $11,345 was converted into 234,767 shares of common stock according to the Merger Agreement. 7 % $ - $ 25,000 In February 2014, we entered into a 12-month term loan agreement with an individual in the amount of $200,000. The note included warrants for 66,146 shares of common stock at $0.73 per share. The warrants expired on February 28, 2017 and none were exercised at that date. The note matured and remains in default. 15 % 150,000 150,000 In March 2014, we entered into a 12-month term loan agreement with an individual in the amount of $500,000. The note included warrants for 681,461 shares of common stock at $0.92 per share. The warrants expired on February 28, 2017 and none were exercised at that date. The note matured and in March 2020 the full outstanding principal balance of $500,000 and unpaid accrued interest of $373,065 was converted into 1,124,802 shares of common stock according to the Merger Agreement. 15 % - 500,000 In March 2014, we entered into a short-term loan agreement with an entity in the amount of $200,000. The note included warrants for 272,584 shares of common stock at $0.94 per share. The warrants expired on February 28, 2017 and none were exercised at that date. The loans matured and remains in default. 8 % 200,000 200,000 In May 2020, we entered into a two year loan with an entity under the Paycheck Protection Program established by the CARES Act in the amount of $159,033. The note requires monthly payments of principal and interest starting in December 2020 and maturing in May 2020. We expect $74,000 of the loan amount to be forgiven in accordance with the CARES Act. 1 % 159,033 - In June 2020, we entered into a six-month loan with an individual in the amount of $100,000. The loan matures in December 2020 with principal and interest due at maturity. 12 % 100,000 - In August 2020, we entered into a nine-month loan with a company in the amount of $112,000. The loan requires 9 amortized payments of principal and interest in the amount of $12,246.66 with the first payment due September 2020. 4.8 % 99,753 $ 703,565 $ 875,000 Interest expense on notes payable was $13,377 and $28,813 for the three months ended September 30, 2020 and 2019, respectively. Interest expense on notes payable was $73,236 and $86,439 for the nine months ended September 30, 2020 and 2019, respectively. Accrued interest was $258,738 and $581,693 at September 30, 2020 and December 31, 2019. Concurrently with the consummation of the Merger, notes payable of $525,000 and accrued interest were converted to shares of Splash common stock, which were exchanged for Splash Beverage Group, Inc. [Formerly known as Canfield Medical Supply, Inc.] shares. Pursuant to the terms of the conversion agreements, these investors have the right to rescind the common shares received and receive replacement notes payable if we fail to raise $9 million in a secondary initial public offering by September 30, 2020 (subsequently extended to April 30, 2021). As a result, these shares are classified as mezzanine equity in our condensed consolidated balance sheet. Interest September 30, December 31, Related Parties Notes Payable During 2012, we entered into two 6-month term loan agreements with an entity, totaling $150,000. The notes included warrants for 68,146 shares of common stock at $0.73 per share which expired unexercised in 2017. The note matured and in March 2020 the full outstanding principal balance of $41,500 and unpaid accrued interest of $31,515 was converted into 98,726 shares of common stock according to the Merger Agreement. 7 % $ - $ 41,500 In March 2014, we entered into a $50,000 12-month term loan agreement. The note included warrants for 136,292 shares of common stock at $0.92 per share. The warrants expired unexercised on February 28, 2017. The note matured and in March 2020 the full outstanding principal balance of $50,000 and unpaid accrued interest of $24,145 was converted into 99,252 shares of common stock according to the Merger Agreement. 8 % - 50,000 During 2015, we entered into a 12-month term loan agreement with an individual in the amount $250,000. The note matured and in March 2020 the full outstanding principal balance of $250,000 and unpaid accrued interest of $101,850 was converted into 98,726 shares of common stock according to the Merger Agreement. 8 % - 250,000 In February 2012, we entered into a loan agreement with an officer of the Company in the amount of $100. On September 25, 2018 an additional $10,500 loan agreement was entered into. The note matured and in March 2020 the full outstanding principal balance of $10,600 and unpaid accrued interest of $1,189 was converted into 15,734 shares of common stock according to the Merger Agreement. 7 % - 10,600 During 2013, 2014, 2015, and 2016, we entered into several 12-month term loan agreements with an officer of the Company in the amounts of $57,000, $225,000, $105,000, and $9,000, respectively. The note matured and in March 2020 the full outstanding principal balance of $396,000 and unpaid accrued interest of $146,828 was converted into 727,344 shares of common stock according to the Merger Agreement. 7 % - 396,000 Interest September 30, December 31, Related Parties Notes Payable, continued During 2012, 2013, 2014, and 2016, we entered into 6-month term loan agreements with an officer of the Company in the amounts of $155,000, $210,000, $150,000 and $40,000, all respectively. The notes included warrants for issuances of 204,438 shares of common stock at $.092 per share. The warrants expired unexercised on March 1, 2017. The note matured and in March 2020 the full outstanding principal balance of $495,000 and unpaid accrued interest of $213,010 was converted into 942,504 shares of common stock according to the Merger Agreement. 7 % - 495,000 During 2013, 2014 and 2017, we entered into 12-month term loan agreements with an officer of the Company in the amounts of $60,000, $50,000 and $10,000. The note matured and in March 2020 the full outstanding principal balance of $120,000 and unpaid accrued interest of $50,305 was converted into 228,328 shares of common stock according to the Merger Agreement. 7 % - 120,000 During 2018, we entered into a long term note payable with an entity owned by an officer for $12,000 to be payable on July 10, 2020. The note matured and in March 2020 the full outstanding principal balance of $12,000 and unpaid accrued interest of $1,050 was converted into 17,407 shares of common stock according to the Merger Agreement. 12 % - 12,000 During 2019, we entered into a term note payable with an entity owned by an officer for $130,000 to be paid on August 8, 2019. The note matured and in March 2020 the full outstanding principal balance of $130,000 and unpaid accrued interest of $9,078 was converted into 182,525 shares of common stock according to the Merger Agreement. 12 % - 130,000 $ - $ 1,505,100 Interest expense on related party notes payable was $0 and $24,714 for the three months ended September 30, 2020 and 2019, respectively. Interest expense on related party notes payable was $37,967 and $74,342 for the nine months ended September 30, 2020 and 2019, respectively. Accrued interest was $0 and $546,362 as of September 30, 2020 and December 31, 2019. Concurrently with the consummation of the Merger, notes payable of $1,505,100 and accrued interest were converted to shares of Splash common stock, which were exchanged for Splash Beverage Group, Inc. [Formerly known as Canfield Medical Supply, Inc.] shares. Pursuant to the terms of the conversion agreements, these investors have the right to rescind the common shares received and receive replacement notes payable if we fail to raise $9 million in a secondary initial public offering by September 30, 2020 (subsequently extended to April 30, 2021). As a result, these shares are classified as mezzanine equity in our condensed consolidated balance sheet. Interest September 30, December 31, Convertible Bridge Loans Payable In May 2015, we entered into a 3-month term loan agreement with an individual in the amount of $100,000. The annual interest rate for this bridge loan was 32% for the first 90 days, and 4% thereafter, compounded monthly. The loan remains in default. See left $ 100,000 $ 100,000 In October 2015, we entered into a 3-month term loan agreement with two individuals in the amount of $25,000. On December 26, 2018, the outstanding principal and accrued interest of $14,388 was consolidated into a new $39,388 term loan due August 26, 2020. In March 2020 the full outstanding principal balance of $39,388 and unpaid accrued interest of $5,973 was converted into 59,694 shares of common stock according to the Merger Agreement. 12 % - 39,388 In June 2015, we entered into a 3-month term loan with two individuals in the amount of $100,000. On December 26, 2018, the outstanding principal amount of $100,000 and accrued interest of $64,307 was consolidated into a new $164,307 term loan due August 26, 2020. In March 2020 the full outstanding principal balance of $164,307 and unpaid accrued interest of $24,916 was converted into 249,013 shares of common stock according to the Merger Agreement. 12 % - 164,307 During 2016, 2017 and 2018, we entered into multiple loan agreements with an entity in varying amounts. On December 26, 2018, the outstanding principal of $235,500 and accrued interest of $155,861 was consolidated into a new $391,361 term due August 26, 2020. In March 2020 the full outstanding principal balance of $391,361 and unpaid accrued interest of $43,823 was converted into 435,184 shares of common stock according to the Merger Agreement. 12 % - 391,361 During 2016, we entered into 3-month term loan agreements with an individual totaling $20,000. The loan was extended to August 14, 2020. In March 2020 the full outstanding principal balance of $20,000 and unpaid accrued interest of $10,096 was converted into 41,336 shares of common stock according to the Merger Agreement. 9 % - 20,000 During 2014 through 2018, we entered into convertible promissory note agreements with various terms ranging from 90 days to 18 months at 18% interest with an entity which were consolidated into one loan at 12% in 2018 totaling $795,137 with a due date of August 26, 2020. In March 2020 the full outstanding principal balance of $795,137 and unpaid accrued interest of $89,037 was converted into 884,174 shares of common stock according to the Merger Agreement. 12 % - 795,137 During 2015 and 2016, we entered into a series of 3-month term convertible promissory note agreements at 18% interest with an entity which were consolidated into one loan at 12% in 2018 totaling $692,471 with a due date of August 26, 2020. In March 2020 the full outstanding principal balance of $692,471 and unpaid accrued interest of $77,541 was converted into 770,012 shares of common stock according to the Merger Agreement. 12 % - 692,471 $ 100,000 $ 2,202,664 During 2018, we issued convertible bridge loans payable which are convertible, at the holders’ option, into shares of our common stock. During 2018 multiple convertible bridge loans payable to five counterparties, and related unpaid interest were consolidated into five new convertible bridge loans payable totaling $2,082,665. The notes are of varying amounts and are due in August 2020, at an interest rate of 12%. We analyzed the notes and concluded the conversion terms did not constitute beneficial conversion features. The principal amount and any accrued and unpaid interest are convertible at the conversion price of a potential future offering of the Company. Interest expense on the convertible bridge loans payable was $8,000 and $70,480 for the three months ended September 30, 2020 and 2019, respectively. Interest expense on the convertible bridge loans payable was $109,785 and $140,960 for the nine months ended September 30, 2020 and 2019, respectively. Accrued interest was $163,215 and $439,344 as of September 30, 2020 and December 31, 2019. On April 24, 2017, a note holder filed a complaint against the Company for a promissory note in default. The note holder is requesting summary judgment in the amount of $263,215. Concurrently with the consummation of the Merger, notes payable of $2,102,664 and accrued interest were converted to shares of Splash common stock, which were exchanged for Splash Beverage Group, Inc. [Formerly known as Canfield Medical Supply, Inc.] shares. Pursuant to the terms of the conversion agreements, these investors have the right to rescind the common shares received and receive replacement notes payable if we fail to raise $9 million in a secondary initial public offering by September 30, 2020 (subsequently extended to April 30, 2021). As a result, these shares are classified as mezzanine equity in our condensed consolidated balance sheet. Interest September 30, December 31, Revenue Financing Arrangements During August 2015, we entered into a 3-month term loan agreement with an entity in the amount of $50,000, with required daily payments of $999. we entered into two additional 3-month loan agreements with the entity in 2016 in the amounts of $60,000 and $57,000, with required daily payments of $928 and $713, respectively. The term loans matured and remains in default. 10 % 28,032 28,032 During November 2016, we entered into a short-term loan agreement with an entity in the amount of $55,000 with required daily payments of $1,299. The note was in default as of December 31, 2018. In 2019, we entered into a settlement agreement with monthly installment payments of $6,000. The loan is scheduled to be fully repaid in 2020. 12 % 17,435 17,435 $ 45,464 $ 45,464 Interest expense on the revenue financing arrangements was $25,067 and $1,723 for the nine months ended September 30, 2020 and 2019, respectively. Accrued interest was $0 and $32,154 at September 30, 2020 and December 31, 2019. Bridge Loan Payable We issued an additional bridge loan in October 2018 for $2 million with a one-year maturity to GMA Bridge Fund LLC (“GMA”). This bridge loan contains a 10% administration fee of which the full $200,000 was accrued at December 31, 2019 and included in bridge loan payable, net. We incurred $271,670 of loan costs, which was fully amortized at December 31, 2019. Interest on the bridge loan was 0.5% monthly for the first six months and 0.75% monthly for the next six months. At the same time the debt was issued, we entered into a separate agreement in which GMA provided consulting services for one year (“Consulting Agreement”). We compensated GMA for the Consulting Agreement services by issuance of a warrant with a 5-year term to acquire 1,362,922 shares of our common stock at an exercise price of $0.01 per share. The warrant vested immediately. The value of the warrant, based on a Black-Scholes option pricing model, was $991,423 and was expensed in full in 2018. Interest expense on the bridge loan for the nine months ended September 30, 2020 was $0 and accrued interest at September 30, 2020 was $0. As part of GMA’s conversion agreement, we replaced the original warrants to purchase 1 million shares and granted additional warrants. To purchase 1 million shares. The value of the warrants based on a Black-Scholes option pricing model, was $1,657,805, and was expensed. Concurrently with the consummation of the Merger, the $2,500,000 note payable of was converted to shares of Splash common stock, which were exchanged for Splash Beverage Group, Inc. [Formerly known as Canfield Medical Supply, Inc.] shares. Pursuant to the terms of the conversion agreements, GMA has the right to rescind the common shares received and receive replacement notes payable if we fail to raise $9 million in a secondary initial public offering by September 30, 2020 (subsequently extended to April 30, 2021). As a result, these shares are classified as mezzanine equity in our condensed consolidated balance sheet.

Licensing Agreement and Royalty

Licensing Agreement and Royalty Payable	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Licensing Agreement and Royalty Payable	Note 5 – Licensing Agreement and Royalty Payable We have a licensing agreement with ABG TapouT, LLC (“TapouT”), providing us with licensing rights to the brand “TapouT” on energy drinks, energy shots, water, teas and sports drinks for beverages sold in the United States of America, its territories, possessions, U.S. military bases and Mexico. Under the terms of the agreement, we are required to pay a 6% royalty on net sales, as defined. In 2020 and 2019, we are required to make monthly payments of $45,000 and $39,000, respectively. There were no unpaid royalties at September 30, 2020. Guaranteed minimum royalty payments totaled $135,000 and $117,000 for the three months ended September 30, 2020 and 2019, which is included in general and administrative expenses. Guaranteed minimum royalty payments totaled $405,000 and $351,000 for the nine months ended September 30, 2020 and 2019, which is included in general and administrative expenses.

Deficiency in Stockholders' Equ

Deficiency in Stockholders' Equity	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Deficiency in Stockholders' Equity	Note 6 – Deficiency in Stockholders’ Equity Series A and B Convertible Preferred Stock As part of the merger consummated on March 31, 2020, all series A and B convertible preferred stock were converted to common stock. If the Company is unable to achieve the capital raise event as defined in the Merger Agreement by September 30, 2020 (subsequently extended to April 30, 2021), these shareholders can rescind their common shares back to preferred shares. Below are the new rights to these shareholders if they decide to rescind: Series A Convertible Preferred Stock Rank. The Series A Preferred Stock shall rank, with respect to dividend rights and to rights upon any voluntary or involuntary liquidation, dissolution or winding up of the Company (each, a “Liquidation Event”), (a) senior in preference and priority to the common stock of the Company (the “Common Stock”) and any other class or series of equity security established and designated by the Board of Directors the terms of which do not expressly provide that it ranks senior in preference or priority to or on parity with the Series A Preferred Stock with respect to dividend rights and rights upon a Liquidation Event (collectively, “Junior Securities”), (b) on parity, without preference or priority, with each other class or series of equity security established and designated by the Board of Directors the terms of which expressly provide that it ranks on parity, without preference or priority to, the Series A Preferred Stock with respect to dividend rights and rights upon a Liquidation Event (collectively, “Parity Securities”), and (c) junior in preference and priority to each other class or series of equity security established and designated by the Board of Directors the terms of which expressly provide that it ranks senior in preference or priority to the Series A Preferred Stock with respect to dividend rights and rights upon a Liquidation Event (collectively, “Senior Securities”). Dividends. Holders of shares of the Series A Preferred Stock are entitled to receive, when, as and if declared by the Board, out of funds legally available for the payment of dividends, cumulative cash dividends at an annual rate of eight percent (8%) of the Original Issue Price per share (equal to $.08 per share per annum). Dividends shall accrue on each share of Series A Preferred Stock from the date of issuance thereof, whether paid or not, and shall be cumulative and compounded annually. Liquidation Preference. In the event of any Liquidation Event, the holders of shares of Series A Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders before any payment shall be made to the holders of any Junior Securities by reason of their ownership thereof, an amount per share equal to one hundred fifty percent (150%) of the Series A Original Issue Price (the “Liquidation Preference”), plus the amount of accrued and unpaid dividends thereon from the Original Issue Date through the date of liquidation. If upon any such Liquidation Event the assets of the Company available for distribution to its stockholders shall be insufficient to pay the holders of shares of Series A Preferred Stock the full amount to which they shall be entitled under this, the holders of shares of Series A Preferred Stock and Parity Securities shall share ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full. Conversion. The holders of Series A Preferred Stock shall have conversion rights as follows (the “Conversion Rights”): Optional Conversion. Each share of Series A Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, into such number of fully paid and non-assessable shares of Common Stock as is determined by dividing the Series A Original Issue Price by the Conversion Price (as defined below) in effect at the time of conversion. The Conversion Price at which shares of Common Stock shall be deliverable upon conversion of Series A Preferred Stock without the payment of additional consideration by the holder thereof (the “Conversion Price”) shall initially be $1.28 per share. Such initial Conversion Price, and the rate at which shares of Series A Preferred Stock may be converted into shares of Common Stock, shall be subject to adjustment as provided below. All accrued and unpaid dividends may be converted by each holder of Series A Preferred Stock into Common Stock by first determining the number of shares of Series A Preferred Stock that could be purchased based on the Series A Original Issue Price then in effect and then determining the number of shares of Common Stock such additional shares of Series A Preferred Stock are convertible into. By way of illustration only, if the accrued and unpaid dividends are equal to $100,000, then based on the Series A Original Issue Price of $1.00 and a Conversion Price of $0.85, the holders of Series A Preferred Stock would receive an additional 85,000 shares of Common Stock. Automatic Conversion. Upon the consummation of an underwritten public offering of the Common Stock of the Company (“IPO”) , each share of Series A Preferred Stock shall automatically be converted into such number of fully paid and non-assessable shares of Common Stock at a Conversion Price equal to the lesser of (i) the Conversion Price in effect immediately prior to the consummation of the IPO or (ii) fifty percent (50%) of the public offering price of the Common Stock in the IPO. All accrued and unpaid dividends may be converted by each holder of Series A Preferred Stock into Common Stock by first determining the number of shares of Series A Preferred Stock that could be purchased based on the Series A Original Issue Price then in effect and then determining the number of shares of Common Stock such additional shares of Series A Preferred Stock are convertible into. By way of illustration only, if the accrued and unpaid dividends are equal to $100,000, then based on the Series A Original Issue Price of $1.00 and a Conversion Price of $0.85, the holders of Series A Preferred Stock would receive an additional 85,000 shares of Common Stock. Series B Convertible Preferred Stock Rank. The Series B Preferred Stock shall rank, with respect to dividend rights and to rights upon any voluntary or involuntary liquidation, dissolution or winding up of the Company (each, a “Liquidation Event”), (a) senior in preference and priority to the common stock of the Company (the “Common Stock”) and any other class or series of equity security established and designated by the Board of Directors the terms of which do not expressly provide that it ranks senior in preference or priority to or on parity with the Series B Preferred Stock with respect to dividend rights and rights upon a Liquidation Event (collectively, “Junior Securities”), (b) on parity, without preference or priority, with the Series A Preferred Stock and with each other class or series of equity security established and designated by the Board of Directors the terms of which expressly provide that it ranks on parity, without preference or priority to, the Series B Preferred Stock with respect to dividend rights and rights upon a Liquidation Event (collectively, “Parity Securities”), and (c) junior in preference and priority to each other class or series of equity security established and designated by the Board of Directors the terms of which expressly provide that it ranks senior in preference or priority to the Series B Preferred Stock with respect to dividend rights and rights upon a Liquidation Event (collectively, “Senior Securities”). Dividends. The holders of the Series B Preferred Stock shall be entitled to receive cash dividends, when, as and if declared by the Board, out of any assets legally available therefor, prior and in preference to any declaration or payment of any dividend on any other class of Preferred Stock, except for the Series A Preferred Stock which shall be paid at the same time as the Series B Preferred Stock is paid, and Common Stock of the Corporation at an annual rate of nine percent (9%) of the Original Issue Price per share (equal to $.09 per share per annum) payable out of legally available funds. Dividends shall accrue on each share of Series B Preferred Stock from the date of issuance thereof, whether paid or not, and shall be cumulative and compounded annually. Such dividends shall be payable on the first day of each January, April, July and October commencing with respect to each share of Series B Preferred Stock, on the first of such dates to occur after the issuance of such share (each such date a “Dividend Payment Date”) to the holders of record at the close of business on the fifteenth day of each December, March, June and September, respectively, subject to declaration of such dividends by the Board. All dividends paid with respect to shares of Series B Preferred Stock shall be paid pro rata to the holders entitled thereto. Dividends, if paid, must be paid, on all outstanding shares of Series B Preferred Stock contemporaneously. If any dividend shall not be paid on a Dividend Payment Date, for any reason, the right of the holders to receive such dividend shall not lapse or terminate but each such dividend shall accrue and be paid to such holders, subject to the conversion provisions below. No dividend shall be paid to the holders of any shares of Common Stock until all dividends, including accrued dividends, then owing to the holders of Series B Preferred Stock, shall have been paid in full. Liquidation Preference. In the event of any Liquidation Event, the holders of shares of Series B Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders before any payment shall be made to the holders of any Junior Securities by reason of their ownership thereof, an amount per share equal to one hundred fifty percent (150%) of the Series B Original Issue Price (the “Liquidation Preference”), plus the amount of accrued and unpaid dividends thereon from the Original Issue Date through the date of liquidation. If upon any such Liquidation Event the assets of the Company available for distribution to its stockholders shall be insufficient to pay the holders of shares of Series B Preferred Stock the full amount to which they shall be entitled under this Section , the holders of shares of Series B Preferred Stock and Parity Securities shall share ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full. Conversion. The holders of Series B Preferred Stock shall have conversion rights as follows (the “Conversion Rights”): Optional Conversion. Each share of Series B Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, into such number of fully paid and non-assessable shares of Common Stock as is determined by dividing the Series B Original Issue Price by the Conversion Price (as defined below) in effect at the time of conversion. The Conversion Price at which shares of Common Stock shall be deliverable upon conversion of Series B Preferred Stock without the payment of additional consideration by the holder thereof (the “Conversion Price”) shall initially be $1.28 per share. Such initial Conversion Price, and the rate at which shares of Series B Preferred Stock may be converted into shares of Common Stock, shall be subject to adjustment as provided below. All accrued and unpaid dividends may be converted by each holder of Series B Preferred Stock into Common Stock by first determining the number of shares of Series B Preferred Stock that could be purchased based on the Series B Original Issue Price then in effect and then determining the number of shares of Common Stock such additional shares of Series B Preferred Stock are convertible into. By way of illustration only, if the accrued and unpaid dividends are equal to $100,000, then based on the Series B Original Issue Price of $1.50 and a Conversion Price of $1.28, the holders of Series B Preferred Stock would receive an additional 78,125 shares of Common Stock. Automatic Conversion. Upon the consummation of an underwritten public offering of the Common Stock of the Company (“IPO”), each share of Series B Preferred Stock shall automatically be converted into such number of fully paid and non-assessable shares of Common Stock at a Conversion Price equal to the lesser of (i) the Conversion Price in effect immediately prior to the consummation of the IPO or (ii) fifty percent (50%) of the public offering price of the Common Stock in the IPO. All accrued and unpaid dividends may be converted by each holder of Series B Preferred Stock into Common Stock by first determining the number of shares of Series B Preferred Stock that could be purchased based on the Series B Original Issue Price then in effect and then determining the number of shares of Common Stock such additional shares of Series B Preferred Stock are convertible into. By way of illustration only, if the accrued and unpaid dividends are equal to $100,000, then based on the Series B Original Issue Price of $1.50 and a Conversion Price of $1.28, the holders of Series B Preferred Stock would receive an additional 78,125 shares of Common Stock. Common Stock In 2019, we issued 1,846,078 shares of our common stock in exchange for services provided to us. The shares were valued at $0.73 per share. We recognized share-based compensation expense of $1,354,500, which is classified within the contracted services line on the Statement of Operations. In Q3 2020, we entered into multiple subscription agreements for $3,429,601 in exchange for 3,391,683 of our common stock. In Q3 2020, we issued 490,652 shares to an existing shareholder under a 3-year consulting agreement dated December 2019. The shareholder fulfilled his deliverables in full and the board approved issuing the shares early. Private Placement Memorandum (PPM) Our Board of Directors has determined that it is in the best interests of the Corporation and its stockholders to obtain working capital by conducting a private placement offering of 2,790,909 shares of the common stock of the Company, no par value per share at a purchase price of $1.10 per share for aggregate gross proceeds of $3,070,000. As part of the PPM, each common share holds one-half warrant. We will issue all shares for subscription agreements executed after September 30, 2020, in Q4 2020. Treasury Stock Since its inception, we have repurchased shares from our shareholders. To date, we have repurchased 1,226,630 shares, of which 817,753 have been retired. In connection with a 2018 consulting agreement, we were committed to issue the 408,877 shares held in treasury upon the occurrence of certain events or milestones. We issued 136,292 shares in July 2018, 136,292 shares in July 2019 and 136,292 shares on March 31, 2020. Warrant Issuance-Common Stock As part of the sale and issuance of 4,088,765 shares of our Series A Convertible Preferred Stock, we issued 4,088,765 warrants to purchase shares of our common stock at a price of $0.73 per share. The warrants had a five-year term and expired during 2019. As an incentive to convert their Series A preferred stock we issued 1,000,000 new warrants to purchase shares of SBG common stock at $0.18 per share. Concurrently with the consummation of the Merger, these warrants were exchanged for 1,362,922 of Splash Beverage Group, Inc. [Formerly known as Canfield Medical Supply, Inc.] shares. These warrants have a 3-year term. Warrant Issuance-Common Stock As part of the sale and issuance of 5,333,675 shares of our Series B Convertible Preferred Stock, we issued 2,666,839 warrants to purchase shares our common stock at a price of $1.10 per share. The warrants have a 5-year term. At September 30, 2020, there are 935,386 warrants outstanding. As part of the sale of 300,000 shares of common stock, we issued 975,000 warrants to purchase shares of our common stock at a price of $0.25 per share. These warrants have a 3-year term. In Q3 2020, the holder exercised all of his warrants and received 975,000 shares of the Company’s common stock.

Share-Based Payments

Share-Based Payments	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Share-Based Payments	Note 7 – Share-Based Payments Warrant Issuance-GMA Consulting Services We issued 1,362,922 warrants to purchase shares of our common stock at $0.007 per share as part of our consulting agreement with GMA, at December 31, 2019, the weighted average life of the outstanding warrants is 3.75 years. The warrants entitle the holder to purchase one share per warrant of the Company’s common stock at a price of $0.01 per share during the five-year period commencing on October 2, 2018, or, if greater, the number of common shares with a market value equivalent to two percent of the enterprise value of the Company at an exercise price of $0.008 per share. As an incentive for GMA to convert their debt and accrued interest into shares of common stock, we retired the original 1,362,922 warrants and issued 2,725,844 pre-merger new warrants to purchase shares of our common stock at $0.18 per share. These warrants have a 3-year term. Stock Plan We have adopted the 2012 Stock Incentive Plan for SBG (the “Plan”), which provides for the grant of common stock and stock options to employees. We have reserved 4,088,765 shares for issuance under the Plan. The option exercise price generally may not be less than the underlying stock’s fair market value at the date of the grant and generally have a term of ten years. On December 31, 2018, the sole option holder at the time, our CEO, exercised his options to purchase 2,657,698 shares of common stock at a purchase price of $0.12 per share, totaling $312,000, which total purchase price was paid by the cancelation of the equivalent amount of debt owed by us to the CEO. On December 7, 2019, our Board of Directors granted 1,124,410 options to certain employees and consultants. None of these options were exercised at September 30, 2020. There are 1,124,410 options issued and outstanding under the Plan at September 30, 2020. As of September 30, 2020, the total number of options available for grant is 306,657. We measure employee stock-based awards at the grant-date fair value and recognizes employee compensation expense on a straight-line basis over the vesting period of the award. Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions, including the fair value of our common stock, and for stock options, the expected life of the option, and expected stock price volatility and exercise price. We used the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value of stock- based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards. The expected life of stock options was estimated using the “simplified method,” which calculates the expected term as the midpoint between the weighted average time to vesting and the contractual maturity, we have limited historical information to develop reasonable expectations about future exercise patterns and employment duration for its stock options grants. The simplified method is based on the average of the vesting tranches and the contractual life of each grant. For stock price volatility, we use comparable public companies as a basis for its expected volatility to calculate the fair value of options granted. The risk-free interest rate is based on U.S. Treasury notes with a term approximating the expected life of the option. The estimation of the number of stock awards that will ultimately vest requires judgment, and to the extent actual results or updated estimates differ from the Company’s current estimates, such amounts are recognized as an adjustment in the period in which estimates are revised. We recognized stock-based compensation expense of $265,589 for the year ended December 31, 2019. There was no unrecognized compensation cost related to stock option awards at September 30, 2020. Concurrently with the consummation of the Merger, options to purchase 825,000 SBG shares were converted to options to purchase 1,124,410 Splash Beverage Group, Inc. [Formerly known as Canfield Medical Supply, Inc.] shares. Weighted Average Options Exercise Price Outstanding - beginning of year 1,124,410 $ 0.77 Granted - Exercised - $ - Cancelled/forfeited - $ - Outstanding - September 30, 2020 1,124,410 $ 0.77 Exercisable at September, 30 2020 1,124,410 $ 0.77 Weighted average grant date fair value of options during year N/A Weighted average duration to expiration of outstanding options at September 30, 2020 4.3

Related Parties

Related Parties	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
Related Parties	Note 8 – Related Parties During the normal course of business, we incurred expenses related to services provided by our CEO or Company expenses paid by our CEO, resulting in related party payables, net of $469,904 as of September 30, 2020. The related party payable to the CEO bears no interest payable and is due on demand. We also assumed a $50,000 note for the President of WesBev who is the majority shareholder of Splash Beverage Group, Inc. [Formerly known as Canfield Medical Supply, Inc.]. There are related party notes payable of $0 outstanding as of September 30, 2020 as discussed in Note 4.

Investment in Salt Tequila USA,

Investment in Salt Tequila USA, LLC	9 Months Ended
	Sep. 30, 2020
Investments, All Other Investments [Abstract]
Investment in Salt Tequila USA, LLC	Note 9 – Investment in Salt Tequila USA, LLC On December 9, 2013, we entered into a marketing and distribution agreement with SALT Tequila USA, LLC (“SALT”) in Mexico for the manufacturing of our product line. The agreement was for a one-year term with an additional two-year renewal. On December 28, 2015, the agreement was extended through 2020. In the December 9, 2013 agreement, we received a 5% ownership interest in SALT, 12 months after the date of the agreement we received an additional 5% ownership interest in SALT, and 24 months after the date of the agreement we received an additional 5% interest, resulting in a total interest of 15% in SALT. We have not recorded the cost of the investment or our share of its results of operations as the amounts are considered immaterial. SALT also has product at a unrelated international alcohol distributor, American Spirits Exchange, for preliminary market testing in 9 of 16 states that they distribute to, that are government-controlled alcohol resellers. In 2019 we had no sales for SALT Tequila. On December 31, 2018, we created a Mexican subsidiary, Splash MEX SA DE CV (“Splash Mex”) for the exporting of SALT Tequila from Mexico to the USA, South and Central Americas. Splash Mex will also act as the manufacturing and distribution agent of TapouT in Central and South Americas. Applications for the appropriate licenses required for import and wholesale of alcohol in the USA have been completed for at the Federal and State levels. These licenses will permit direct alcohol sales to distributors and wholesalers thereby limiting the use of agents for importing SALT Tequila to the USA for distribution. On March 26, 2020, we entered into a new amended stock sale and purchase agreement. The agreement is for $1,000,000 to be paid in 4 tranches of $250,000 and entitles us to additional equity interest in Salt Tequila USA, LLC as follows: ● Tranche 1 – 7.5% ● Tranche 2 – 5.0% ● Tranche 3 – 5.0% ● Tranche 4 – 5.0% Once all tranches are paid-out we will have a total equity stake of 37.5% of Salt Tequila USA, LLC.

Operating Lease Obligations

Operating Lease Obligations	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Operating Lease Obligations	Note 10 – Operating Lease Obligations Effective July 2018, we entered into a lease agreement for the right to use and occupy office space. The lease term commenced July 1, 2018 and is scheduled to expire after 36 months, on June 30, 2021. Prior to the current lease, we entered into a lease agreement in 2014 for the right to use and occupy office space. The lease term commenced November 1, 2014 and was scheduled to expire after 62 months, on March 31, 2020. The lease was terminated in February 2018. Effective November 2019, we entered into a new lease agreement for our NY affiliate. The lease was for six months and had expired on April 30, 2020. This lease was not subjected to the new lease standard, Topic 842. Effective November 2019, we entered into a new lease with Interport Logistics, LLC. The lease term commenced on November 11, 2019 and is scheduled to expire on November 11, 2020. Effective May 2019, we entered into a new lease in Mexico. The lease commenced May 1, 2019 and is scheduled to expire after 24 months, on April 1, 2021. The following table presents the discounted present value of minimum lease payments for our office and warehouses to the amounts reported as financial lease liabilities on the condensed consolidated balance sheet at September 30, 2020: Undiscounted Future Minimum Lease Payments Operating Lease 2020 $ 22,172 2021 59,291 Thereafter 25,910 Total 107,372 Amount representing imputed interest (4,136 ) Total operating lease liability 103,237 Current portion of operating lease liability 70,297 Operating lease liability, non-current $ 32,940 The table below presents information for lease costs related to our operating leases at September 30, 2020: Operating lease cost: Amortization of leased assets $ 114,032 Interest of lease liabilities 10,776 Total operating lease cost $ 124,808 The table below presents lease-related terms and discount rates at September 30, 2020: Remaining term on leases 9 to 25 months Incremented borrowing rate 5.0 %

Line of Credit

Line of Credit	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Line of Credit	Note 11 – Line of Credit At September 30, 2020 SBG owed $68,000 to a financial institution under a revolving line of credit.. The line of credit is secured by the assets of SBG is due on demand, and bears interest at variable rates approximately 6.1% at September 30, 2020. Interest expense under the note was approximately $300 during the three months ended September 30, 2020. Interest expense under the note was approximately $2,300 during the nine months ended September 30, 2020.

PPP Loan

PPP Loan	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
PPP Loan	Note 12 – PPP Loan On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond the point of origin. On March 20, 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. In response to the COVID-19 outbreak in the United States, the CARES Act (the “Act”) was passed by Congress and signed into law on March 27, 2020. In connection with the CARES Act, the Company and its subsidiary applied for and received loans with an original aggregate principal balance of approximately $158,000. These loans and interest will be forgiven as long as the funds are used for qualifying expenditures as outlined in the Act. The loans bear interest at 1%, with an 18 month term, and has a 6-month initial payment deferral.

Business Combinations

Business Combinations	9 Months Ended
	Sep. 30, 2020
Business Combinations [Abstract]
Business Combinations	Note 13 – Business Combinations As stated in Note 1, we consummated the merger of SBG on March 31, 2020 which was accounted for as a reverse merger. The value of our merger was approximately $9.2 million based on the valuation of the SBG equity on the date of consummation. The following summarizes our allocation of the purchase price for the acquisition: Cash and cash equivalents $ 72,442 Accounts receivable $ 311,586 Inventory $ 21,415 Property and equipment $ 38,110 Goodwill $ 9,448,832 Accounts payable, accrued expenses and other liabilities $ 719,221 Purchase price $ 9,173,164

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Segment Reporting	Note 14 – Segment Reporting The Company evaluates segment reporting in accordance with the FASB Accounting Standards Codification Topic 280, Segment Reporting, each reporting period, including evaluating the reporting package reviewed by the Chief Executive Officer and Chief Financial Officer. Three-Months Ending Nine-Months Ending Revenue September 30, September 30, September 30, September 30, Splash Beverage Group 91,778 - 213,174 14,445 B2C Business 601,196 - 1,004,536 32,641 Medical Devices 316,641 - 516,217 - Total Revenues 1,009,615 - 1,733,926 47,086 Total assets Sep-20 Dec-19 Splash Beverage Group 2,725,853 446,288 B2C Business 435,933 159,026 Medical Devices 9,875,151 - Total Assets 13,036,937 605,314

Commitment and Contingencies

Commitment and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitment and Contingencies	Capital Raise In connection with the merger we are committed to our previous preferred stock and debt holders to raise $9 million in a secondary IPO, private placement and debt as defined in the agreements. There cannot be any assurance that we will raise this capital as required. Stock Price Guarantee We have a commitment to issue additional shares associated with specific stock price guarantee granted to an investor. See Note 4.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 16 – Subsequent Events Subscription Agreements In Q4 2020, we entered into multiple subscription agreements for $1,895,000 in exchange for 1,722,727 of our common stock at $1.10 per share as well as warrants to purchase 861,361 shares of our common stock at $1.10 per share. 2020 Incentive Plan In October 2020, our board approved the granting of both shares and warrants to purchase shares to existing employees as well as consultants. International Distribution Agreement The Company entered into a distribution agreement with China-based American Software Capital (“ASC”), resulting in securing distribution and Manufacturing capabilities in Greater China for its TapouT Performance brand and distribution for its SALT Naturally Flavored Tequila brand.

Summary of Significant Accounti

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation These condensed consolidated financial statements include the accounts of Splash Beverage Group and its wholly owned subsidiaries, Holdings and Splash Mex, in addition to the accounts of the CMS from March 31, 2020, the merger consummation date. All intercompany balances have been eliminated in consolidation. Our accounting and reporting policies conform to accounting principles generally accepted in the United States of America (GAAP). The accompanying condensed consolidated financial statements have been prepared by us without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the nine months ended September 30, 2020 and 2019 have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in our December 31, 2019 audited financial statements. The results of operations for the period ended September 30, 2020 are not necessarily indicative of the operating results for the full year.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash Equivalents and Concentration of Cash Balance	Cash Equivalents and Concentration of Cash Balance We consider all highly liquid securities with an original maturity of three months or less to be cash equivalents. We had no cash equivalents at September 30, 2020 or December 31, 2019. Our cash in bank deposit accounts, at times, may exceed federally insured limits of $250,000. At September 30, 2020 we had bank accounts over the federally insured limits. Our bank deposit accounts in Mexico are uninsured.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are carried at their estimated collectible amounts and are periodically evaluated for collectability based on past credit history with clients and other factors. We establish provisions for losses on accounts receivable on the basis of loss experience, known and inherent risk in the account balance, and current economic conditions. At September 30, 2020 and December 31, 2019, our accounts receivable amounts are reflected net of allowances of $547,498 and $11,430, respectively.
Inventory	Inventory Inventory is stated at the lower of cost or net realizable value, accounted for using the weighted average cost method. The inventory balances at September 30, 2020 and December 31, 2019 consisted of finished goods held for distribution. The cost elements of inventory consist of purchase of products, transportation, and warehousing. We establish provisions for excess or inventory near expiration are based on management’s estimates of forecast turnover of inventories on hand and under contract. A significant change in the timing or level of demand for certain products as compared to forecast amounts may result in recording additional provisions for excess or expired inventory in the future. Provisions for excess inventory are included in cost of goods sold and have historically been adequate to provide for losses on inventory. We manage inventory levels and purchase commitments in an effort to maximize utilization of inventory on hand and under commitments.
Property and Equipment	Property and Equipment We record property and equipment at cost when purchased. Depreciation is recorded for property, equipment, and software using the straight-line method over the estimated economic useful lives of assets, which range from 3-10 years. Company management reviews the recoverability of all long-lived assets, including the related useful lives, whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset might not be recoverable. Depreciation expense totaled $7,530 and $2,377 for the three months ended September 30, 2020 and September 30, 2019, respectively. Depreciation expense totaled $26,339 and $7,088 for the nine months ended September 30, 2020 and September 30, 2019, respectively. Property and equipment as of September 30, 2020 and December 31, 2019 consisted of the following: September 30, December 31, Property and equipment, at cost 208,440 88,758 Accumulated depreciation (149,268 ) (51,029 ) Property and equipment, net 59,172 37,729
Licensing Agreements	Licensing Agreements The initial amount of the TapouT agreement as entered into by one of the founders prior to the Company’s assumption in 2013 was $4,000,000 to be paid over several years pursuant to a guaranteed minimum royalty agreement. Royalty costs incurred under the agreements, guaranteed minimum royalty amounts, are expensed as incurred. We have not made any payments to Salt Tequila USA, LLC under the licensing agreement due to the immaterial level of our sales to date from the brand.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Financial Accounting Standards (“FASB”) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 3 - Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The liabilities and indebtedness presented on the condensed consolidated financial statements approximate fair values at September 30, 2020 and December 31, 2019, consistent with recent negotiations of notes payable and due to the short duration of maturities.
Convertible Instruments	Convertible Instruments U.S. GAAP requires the bifurcation of certain conversion rights contained in convertible indebtedness and account for them as free standing derivative financial instruments according to certain criteria. This criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional as that term is described under applicable U.S. GAAP. When bifurcation is required, the embedded conversion options are bifurcated from the convertible note, resulting in the recognition of discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. With respect to convertible preferred stock, we record a dividend for the intrinsic value of conversion options embedded in preferred securities based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.
Revenue recognition	Revenue Recognition We recognize revenue under ASC 606, Revenue from Contracts with Customers (Topic 606). This guidance sets forth a five-step model which depicts the recognition of revenue in an amount that reflects what we expect to receive in exchange for the transfer of goods or services to customers. We recognize revenue when our performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control of our products is transferred upon delivery to the customer. Revenue is measured as the amount of consideration that we expect to receive in exchange for transferring goods and is presented net of provisions for customer returns and allowances. The amount of consideration we receive and revenue we recognize varies with changes in customer incentives we offer to our customers and their customers. Sales taxes and other similar taxes are excluded from revenue. Distribution expenses to transport our products, where applicable, and warehousing expense after manufacture are accounted for within operating expenses.
Cost of Goods Sold	Cost of Goods Sold Cost of goods sold include the costs of products, packaging, transportation, warehousing, and costs associated with valuation allowances for expired, damaged or impaired inventory.
Stock-Based Compensation	Stock-Based Compensation We account for stock-based compensation in accordance with ASC 718, “ Compensation - Stock Compensation”
Income Taxes	Income Taxes We use the liability method of accounting for income taxes as set forth in ASC 740, “ Income Taxes” Company management assesses its income tax positions and records tax benefits for all years subject to examination based upon its evaluation of the facts, circumstances and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, our policy is to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit will be recognized in the financial statements. Company management has determined that there are no material uncertain tax positions at September 30, 2020 and December 31, 2019.
Net loss per share	Net loss per share The net loss per share is computed by dividing the net loss by the weighted average number of shares of common outstanding. Warrants, stock options, and common stock issuable upon the conversion of the Company's convertible debt or preferred stock (if any), are not included in the computation if the effect would be anti-dilutive. Three-months Three-months Nine-months Nine-months September 30, September 30, September 30, September 30, Numerator Net loss applicable to common shareholders $ (2,283,683 ) $ (1,067,246 ) $ (6,105,812 ) $ (2,692,629 ) Denominator Weighted average number of common shares outstanding 58,397,694 40,570,619 53,108,031 41,228,247 Net loss per share (basic diluted) $ (0.04 ) $ (0.03 ) $ (0.11 ) $ (0.07 ) Weighted average number of shares outstanding excludes anti-dilutive common stock equivalents, including warrants to purchase 3 million shares of common stock for nominal consideration.
Advertising	Advertising We conduct advertising for the promotion of our products. In accordance with ASC 720-35, advertising costs are charged to operations when incurred.
Related Parties	Related Parties We are indebted to certain members of our Board of Directors at September 30, 2020 and December 31, 2019. Transactions between us and the Board members are summarized in Notes 4 and 8.
Goodwill	Goodwill Goodwill represents the excess of acquisition cost over the fair value of the net assets acquired and is not subject to amortization. The Company reviews goodwill annually in the fourth quarter for impairment or when circumstances indicate carrying value may exceed the fair value. This evaluation is performed at the reporting unit level. If a qualitative assessment indicates that it is more likely than not that the fair value is less than carrying value, a quantitative analysis is completed using either the income or market approach, or a combination of both. The income approach estimates fair value based on expected discounted future cash flows, while the market approach uses comparable public companies and transactions to develop metrics to be applied to historical and expected future operating results.
Long-lived assets	Long-lived assets The Company evaluates long-lived assets for impairment on an annual basis, when relocating or closing a facility, or when events or changes in circumstances may indicate the carrying amount of the asset group, generally an individual warehouse, may not be fully recoverable. For asset groups held and used, including warehouses to be relocated, the carrying value of the asset group is considered recoverable when the estimated future undiscounted cash flows generated from the use and eventual disposition of the asset group exceed the respective carrying value. In the event that the carrying value is not considered recoverable, an impairment loss is recognized for the asset group to be held and used equal to the excess of the carrying value above the estimated fair value of the asset group. For asset groups classified as held-for-sale (disposal group), the carrying value is compared to the disposal group’s fair value less costs to sell. The Company estimates fair value by obtaining market appraisals from third party brokers or using other valuation techniques.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, “ Leases We adopted the standard on January 1, 2019, using the modified retrospective method. The adoption of this standard resulted in recognition of a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, for all leases with a term greater than 12 months. When available, we would use the rate implicit in the lease to discount lease payments to present value. However, our leases generally do not provide a readily determinable implicit rate. Therefore, our management estimates the incremental borrowing rate to discount lease payments based on the information at the lease commencement. The accounting for finance leases is substantially unchanged. Given the nature of our operation, the adoption of Topic 842 did not have a material impact on our balance sheet, statement of income, or liquidity. Refer to Note 10 – Operating Lease Obligations for information regarding our adoption of Topic 842 and the Company’s undiscounted future lease payments and the timing of those payments. Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Schedule of Property and equipment	Property and equipment as of September 30, 2020 and December 31, 2019 consisted of the following: September 30, December 31, Property and equipment, at cost 208,440 88,758 Accumulated depreciation (149,268 ) (51,029 ) Property and equipment, net 59,172 37,729
Schedule of Earnings Per Share, Basic and Diluted	Warrants, stock options, and common stock issuable upon the conversion of the Company's convertible debt or preferred stock (if any), are not included in the computation if the effect would be anti-dilutive. Three-months Three-months Nine-months Nine-months September 30, September 30, September 30, September 30, Numerator Net loss applicable to common shareholders $ (2,283,683 ) $ (1,067,246 ) $ (6,105,812 ) $ (2,692,629 ) Denominator Weighted average number of common shares outstanding 58,397,694 40,570,619 53,108,031 41,228,247 Net loss per share (basic diluted) $ (0.04 ) $ (0.03 ) $ (0.11 ) $ (0.07 )

Notes Payable, Related Party _2

Notes Payable, Related Party Notes Payable, Convertible Bridge Loans Payable, Revenue Financing Arrangements (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Payables [Member]
Schedule of debt	Notes payable are generally nonrecourse and secured by all Company owned assets. Interest September 30, December 31, Notes Payable In October 2013, we entered into a short-term loan agreement with an entity in the amount of $25,000. The note matured and in March 2020 the full outstanding principal balance of $25,000 and unpaid accrued interest of $11,345 was converted into 234,767 shares of common stock according to the Merger Agreement. 7 % $ - $ 25,000 In February 2014, we entered into a 12-month term loan agreement with an individual in the amount of $200,000. The note included warrants for 66,146 shares of common stock at $0.73 per share. The warrants expired on February 28, 2017 and none were exercised at that date. The note matured and remains in default. 15 % 150,000 150,000 In March 2014, we entered into a 12-month term loan agreement with an individual in the amount of $500,000. The note included warrants for 681,461 shares of common stock at $0.92 per share. The warrants expired on February 28, 2017 and none were exercised at that date. The note matured and in March 2020 the full outstanding principal balance of $500,000 and unpaid accrued interest of $373,065 was converted into 1,124,802 shares of common stock according to the Merger Agreement. 15 % - 500,000 In March 2014, we entered into a short-term loan agreement with an entity in the amount of $200,000. The note included warrants for 272,584 shares of common stock at $0.94 per share. The warrants expired on February 28, 2017 and none were exercised at that date. The loans matured and remains in default. 8 % 200,000 200,000 In May 2020, we entered into a two year loan with an entity under the Paycheck Protection Program established by the CARES Act in the amount of $159,033. The note requires monthly payments of principal and interest starting in December 2020 and maturing in May 2020. We expect $74,000 of the loan amount to be forgiven in accordance with the CARES Act. 1 % 159,033 - In June 2020, we entered into a six-month loan with an individual in the amount of $100,000. The loan matures in December 2020 with principal and interest due at maturity. 12 % 100,000 - In August 2020, we entered into a nine-month loan with a company in the amount of $112,000. The loan requires 9 amortized payments of principal and interest in the amount of $12,246.66 with the first payment due September 2020. 4.8 % 99,753 $ 703,565 $ 875,000
Related Party Notes Payable [Member]
Schedule of debt	Interest September 30, December 31, Related Parties Notes Payable During 2012, we entered into two 6-month term loan agreements with an entity, totaling $150,000. The notes included warrants for 68,146 shares of common stock at $0.73 per share which expired unexercised in 2017. The note matured and in March 2020 the full outstanding principal balance of $41,500 and unpaid accrued interest of $31,515 was converted into 98,726 shares of common stock according to the Merger Agreement. 7 % $ - $ 41,500 In March 2014, we entered into a $50,000 12-month term loan agreement. The note included warrants for 136,292 shares of common stock at $0.92 per share. The warrants expired unexercised on February 28, 2017. The note matured and in March 2020 the full outstanding principal balance of $50,000 and unpaid accrued interest of $24,145 was converted into 99,252 shares of common stock according to the Merger Agreement. 8 % - 50,000 During 2015, we entered into a 12-month term loan agreement with an individual in the amount $250,000. The note matured and in March 2020 the full outstanding principal balance of $250,000 and unpaid accrued interest of $101,850 was converted into 98,726 shares of common stock according to the Merger Agreement. 8 % - 250,000 In February 2012, we entered into a loan agreement with an officer of the Company in the amount of $100. On September 25, 2018 an additional $10,500 loan agreement was entered into. The note matured and in March 2020 the full outstanding principal balance of $10,600 and unpaid accrued interest of $1,189 was converted into 15,734 shares of common stock according to the Merger Agreement. 7 % - 10,600 During 2013, 2014, 2015, and 2016, we entered into several 12-month term loan agreements with an officer of the Company in the amounts of $57,000, $225,000, $105,000, and $9,000, respectively. The note matured and in March 2020 the full outstanding principal balance of $396,000 and unpaid accrued interest of $146,828 was converted into 727,344 shares of common stock according to the Merger Agreement. 7 % - 396,000 During 2012, 2013, 2014, and 2016, we entered into 6-month term loan agreements with an officer of the Company in the amounts of $155,000, $210,000, $150,000 and $40,000, all respectively. The notes included warrants for issuances of 204,438 shares of common stock at $.092 per share. The warrants expired unexercised on March 1, 2017. The note matured and in March 2020 the full outstanding principal balance of $495,000 and unpaid accrued interest of $213,010 was converted into 942,504 shares of common stock according to the Merger Agreement. 7 % - 495,000 During 2013, 2014 and 2017, we entered into 12-month term loan agreements with an officer of the Company in the amounts of $60,000, $50,000 and $10,000. The note matured and in March 2020 the full outstanding principal balance of $120,000 and unpaid accrued interest of $50,305 was converted into 228,328 shares of common stock according to the Merger Agreement. 7 % - 120,000 During 2018, we entered into a long term note payable with an entity owned by an officer for $12,000 to be payable on July 10, 2020. The note matured and in March 2020 the full outstanding principal balance of $12,000 and unpaid accrued interest of $1,050 was converted into 17,407 shares of common stock according to the Merger Agreement. 12 % - 12,000 During 2019, we entered into a term note payable with an entity owned by an officer for $130,000 to be paid on August 8, 2019. The note matured and in March 2020 the full outstanding principal balance of $130,000 and unpaid accrued interest of $9,078 was converted into 182,525 shares of common stock according to the Merger Agreement. 12 % - 130,000 $ - $ 1,505,100
Convertible Bridge Loans Payable [Member]
Schedule of debt	Interest September 30, December 31, Convertible Bridge Loans Payable In May 2015, we entered into a 3-month term loan agreement with an individual in the amount of $100,000. The annual interest rate for this bridge loan was 32% for the first 90 days, and 4% thereafter, compounded monthly. The loan remains in default. See left $ 100,000 $ 100,000 In October 2015, we entered into a 3-month term loan agreement with two individuals in the amount of $25,000. On December 26, 2018, the outstanding principal and accrued interest of $14,388 was consolidated into a new $39,388 term loan due August 26, 2020. In March 2020 the full outstanding principal balance of $39,388 and unpaid accrued interest of $5,973 was converted into 59,694 shares of common stock according to the Merger Agreement. 12 % - 39,388 In June 2015, we entered into a 3-month term loan with two individuals in the amount of $100,000. On December 26, 2018, the outstanding principal amount of $100,000 and accrued interest of $64,307 was consolidated into a new $164,307 term loan due August 26, 2020. In March 2020 the full outstanding principal balance of $164,307 and unpaid accrued interest of $24,916 was converted into 249,013 shares of common stock according to the Merger Agreement. 12 % - 164,307 During 2016, 2017 and 2018, we entered into multiple loan agreements with an entity in varying amounts. On December 26, 2018, the outstanding principal of $235,500 and accrued interest of $155,861 was consolidated into a new $391,361 term due August 26, 2020. In March 2020 the full outstanding principal balance of $391,361 and unpaid accrued interest of $43,823 was converted into 435,184 shares of common stock according to the Merger Agreement. 12 % - 391,361 During 2016, we entered into 3-month term loan agreements with an individual totaling $20,000. The loan was extended to August 14, 2020. In March 2020 the full outstanding principal balance of $20,000 and unpaid accrued interest of $10,096 was converted into 41,336 shares of common stock according to the Merger Agreement. 9 % - 20,000 During 2014 through 2018, we entered into convertible promissory note agreements with various terms ranging from 90 days to 18 months at 18% interest with an entity which were consolidated into one loan at 12% in 2018 totaling $795,137 with a due date of August 26, 2020. In March 2020 the full outstanding principal balance of $795,137 and unpaid accrued interest of $89,037 was converted into 884,174 shares of common stock according to the Merger Agreement. 12 % - 795,137 During 2015 and 2016, we entered into a series of 3-month term convertible promissory note agreements at 18% interest with an entity which were consolidated into one loan at 12% in 2018 totaling $692,471 with a due date of August 26, 2020. In March 2020 the full outstanding principal balance of $692,471 and unpaid accrued interest of $77,541 was converted into 770,012 shares of common stock according to the Merger Agreement. 12 % - 692,471 $ 100,000 $ 2,202,664
Revenue Financing Arrangements [Member]
Schedule of debt	Interest September 30, December 31, Revenue Financing Arrangements During August 2015, we entered into a 3-month term loan agreement with an entity in the amount of $50,000, with required daily payments of $999. we entered into two additional 3-month loan agreements with the entity in 2016 in the amounts of $60,000 and $57,000, with required daily payments of $928 and $713, respectively. The term loans matured and remains in default. 10 % 28,032 28,032 During November 2016, we entered into a short-term loan agreement with an entity in the amount of $55,000 with required daily payments of $1,299. The note was in default as of December 31, 2018. In 2019, we entered into a settlement agreement with monthly installment payments of $6,000. The loan is scheduled to be fully repaid in 2020. 12 % 17,435 17,435 $ 45,464 $ 45,464

Share-Based Payments (Tables)

Share-Based Payments (Tables)	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Schedule of Stock Options Activity	Concurrently with the consummation of the Merger, options to purchase 825,000 SBG shares were converted to options to purchase 1,124,410 Splash Beverage Group, Inc. [Formerly known as Canfield Medical Supply, Inc.] shares. Weighted Average Options Exercise Price Outstanding - beginning of year 1,124,410 $ 0.77 Granted - Exercised - $ - Cancelled/forfeited - $ - Outstanding - September 30, 2020 1,124,410 $ 0.77 Exercisable at September, 30 2020 1,124,410 $ 0.77 Weighted average grant date fair value of options during year N/A Weighted average duration to expiration of outstanding options at September 30, 2020 4.3

Operating Lease Obligations (Ta

Operating Lease Obligations (Tables)	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Maturities of lease liabilities	The following table presents the discounted present value of minimum lease payments for our office and warehouses to the amounts reported as financial lease liabilities on the condensed consolidated balance sheet at September 30, 2020: Undiscounted Future Minimum Lease Payments Operating Lease 2020 $ 22,172 2021 59,291 Thereafter 25,910 Total 107,372 Amount representing imputed interest (4,136 ) Total operating lease liability 103,237 Current portion of operating lease liability 70,297 Operating lease liability, non-current $ 32,940
Lease costs	The table below presents information for lease costs related to our operating leases at September 30, 2020: Operating lease cost: Amortization of leased assets $ 114,032 Interest of lease liabilities 10,776 Total operating lease cost $ 124,808
Summary of lease-related terms and discount rates	The table below presents lease-related terms and discount rates at September 30, 2020: Remaining term on leases 9 to 25 months Incremented borrowing rate 5.0 %

Business Combinations (Tables)

Business Combinations (Tables)	9 Months Ended
	Sep. 30, 2020
Business Combinations [Abstract]
Schedule of Business Acquisitions, by Acquisition	The following summarizes our allocation of the purchase price for the acquisition: Cash and cash equivalents $ 72,442 Accounts receivable $ 311,586 Inventory $ 21,415 Property and equipment $ 38,110 Goodwill $ 9,448,832 Accounts payable, accrued expenses and other liabilities $ 719,221 Purchase price $ 9,173,164

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information	The Company evaluates segment reporting in accordance with the FASB Accounting Standards Codification Topic 280, Segment Reporting, each reporting period, including evaluating the reporting package reviewed by the Chief Executive Officer and Chief Financial Officer. Three-Months Ending Nine-Months Ending Revenue September 30, September 30, September 30, September 30, Splash Beverage Group 91,778 - 213,174 14,445 B2C Business 601,196 - 1,004,536 32,641 Medical Devices 316,641 - 516,217 - Total Revenues 1,009,615 - 1,733,926 47,086 Total assets Sep-20 Dec-19 Splash Beverage Group 2,693,066 446,288 B2C Business 435,933 159,026 Medical Devices 9,875,151 - Total Assets 13,004,150 605,314

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Property and equipment, at cost	$ 208,440	$ 88,758
Accumulated depreciation	(149,268)	(51,029)
Property and equipment, net	$ 59,172	$ 37,729

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details 1) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Accounting Policies [Abstract]
Net loss applicable to common shareholders	$ (2,283,682)	$ (1,067,246)	$ (6,105,811)	$ (2,692,629)
Weighted average number of common shares outstanding	58,397,694	40,570,619	53,108,031	41,228,247
Net loss per share (basic diluted)	$ (0.04)	$ (0.03)	$ (0.11)	$ (0.07)

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Depreciation expense	$ 7,530	$ 2,377	$ 26,339	$ 7,088
Accounts Receivable, net	547,498		547,498		$ 11,430
Cash equivalents	0		0		$ 0
Federally insured limits	$ 250,000		$ 250,000
Potentially dilutive shares			3,000,000
Minimum [Member]
Property and Equipment useful life			3 years
Maximum [Member]
Property and Equipment useful life			10 years

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net losses	$ (6,105,811)	$ (2,692,629)
Accumulated deficit	(39,018,841)		$ (31,845,508)
Working capital	800,000
Debt default	$ 900,000

Notes Payable, Related Party _3

Notes Payable, Related Party Notes Payable, Convertible Bridge Loans Payable, Revenue Financing Arrangements (Details) - USD ($)	1 Months Ended	9 Months Ended
	Mar. 27, 2020	Sep. 30, 2020	Dec. 31, 2019
Interest Rate	1.00%
Notes Payable		$ 703,565	$ 875,000
Principal amount	$ 158,000
Warrant issued		975,000
Stock Price		$ 0.25
Notes Payable 1 [Member]
Interest Rate		7.00%
Notes Payable			25,000
Principal amount		$ 25,000
Maturity Date		Mar. 31, 2020
Stock issued for conversion of debt, shares		234,767
Notes Payable 1 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 25,000
Notes Payable 1 [Member] | Principal
Stock issued for conversion of debt		$ 11,345
Notes Payable 2 [Member]
Interest Rate		15.00%
Notes Payable		$ 150,000	150,000
Principal amount		$ 200,000
Warrant issued		66,146
Stock Price		$ 0.73
Warrants expired date		Feb. 28, 2017
Notes Payable 3 [Member]
Interest Rate		15.00%
Notes Payable			500,000
Principal amount		$ 500,000
Maturity Date		Mar. 31, 2020
Stock issued for conversion of debt, shares		1,124,802
Warrant issued		681,461
Stock Price		$ .92
Warrants expired date		Feb. 28, 2017
Notes Payable 3 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 373,065
Notes Payable 3 [Member] | Principal
Stock issued for conversion of debt		$ 500,000
Notes Payable 4 [Member]
Interest Rate		8.00%
Notes Payable		$ 200,000	200,000
Principal amount		$ 200,000
Warrant issued		272,584
Stock Price		$ 0.94
Warrants expired date		Feb. 28, 2017
Notes Payable 5 [Member]
Interest Rate		1.00%
Notes Payable		$ 159,033
Principal amount		$ 159,033
Maturity Date		May 31, 2020
Loan forgiven		$ 74,000
Notes Payable 6 [Member]
Interest Rate		12.00%
Notes Payable		$ 100,000
Principal amount		$ 100,000
Maturity Date		Dec. 31, 2020
Notes Payable 7 [Member]
Interest Rate		4.80%
Notes Payable		$ 99,753
Principal amount		$ 112,000

Notes Payable, Related Party _4

Notes Payable, Related Party Notes Payable, Convertible Bridge Loans Payable, Revenue Financing Arrangements (Details 1) - USD ($)	1 Months Ended	9 Months Ended
	Mar. 27, 2020	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Interest Rate	1.00%
Related Parties Notes Payable			$ 1,505,100
Principal amount	$ 158,000
Warrant issued		975,000
Stock Price		$ 0.25
Related Parties Notes Payable 1 [Member]
Interest Rate		7.00%
Related Parties Notes Payable			41,500
Principal amount		$ 150,000
Maturity Date		Mar. 31, 2020
Stock issued for conversion of debt, shares		98,726
Warrant issued		68,146
Stock Price		$ 0.73
Warrants expired date		Dec. 31, 2017
Related Parties Notes Payable 1 [Member] | Principal
Stock issued for conversion of debt		$ 41,500
Related Parties Notes Payable 1 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 31,515
Related Parties Notes Payable 2 [Member]
Interest Rate		8.00%
Related Parties Notes Payable			50,000
Principal amount		$ 50,000
Maturity Date		Mar. 31, 2020
Stock issued for conversion of debt, shares		99,252
Warrant issued		136,292
Stock Price		$ 0.92
Warrants expired date		Feb. 28, 2017
Related Parties Notes Payable 2 [Member] | Principal
Stock issued for conversion of debt		$ 50,000
Related Parties Notes Payable 2 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 24,145
Related Parties Notes Payable 3 [Member]
Interest Rate		8.00%
Related Parties Notes Payable			250,000
Principal amount		$ 250,000
Maturity Date		Mar. 31, 2020
Stock issued for conversion of debt, shares		98,726
Related Parties Notes Payable 3 [Member] | Principal
Stock issued for conversion of debt		$ 250,000
Related Parties Notes Payable 3 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 101,850
Related Parties Notes Payable 4 [Member]
Interest Rate		7.00%
Related Parties Notes Payable			10,600
Principal amount		$ 10,600
Maturity Date		Mar. 31, 2020
Stock issued for conversion of debt, shares		15,734
Related Parties Notes Payable 4 [Member] | Principal
Stock issued for conversion of debt		$ 10,600
Related Parties Notes Payable 4 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 1,189
Related Parties Notes Payable 5 [Member]
Interest Rate		7.00%
Related Parties Notes Payable			396,000
Principal amount					$ 9,000	$ 105,000	$ 225,000	$ 57,000
Maturity Date		Mar. 31, 2020
Stock issued for conversion of debt, shares		727,344
Related Parties Notes Payable 5 [Member] | Principal
Stock issued for conversion of debt		$ 396,000
Related Parties Notes Payable 5 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 146,828
Related Parties Notes Payable 6 [Member]
Interest Rate		7.00%
Related Parties Notes Payable			495,000
Principal amount					$ 40,000		150,000	210,000	$ 155,000
Maturity Date		Mar. 31, 2020
Stock issued for conversion of debt, shares		942,504
Warrant issued		204,438
Stock Price		$ 0.92
Related Parties Notes Payable 6 [Member] | Principal
Stock issued for conversion of debt		$ 495,000
Related Parties Notes Payable 6 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 213,010
Related Parties Notes Payable 7 [Member]
Interest Rate		7.00%
Related Parties Notes Payable			120,000
Principal amount				$ 10,000			$ 50,000	$ 60,000
Maturity Date		Mar. 31, 2020
Stock issued for conversion of debt, shares		228,328
Related Parties Notes Payable 7 [Member] | Principal
Stock issued for conversion of debt		$ 120,000
Related Parties Notes Payable 7 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 50,305
Related Parties Notes Payable 8 [Member]
Interest Rate		12.00%
Related Parties Notes Payable			12,000
Principal amount		$ 12,000
Maturity Date		Mar. 31, 2020
Stock issued for conversion of debt, shares		17,407
Related Parties Notes Payable 8 [Member] | Principal
Stock issued for conversion of debt		$ 12,000
Related Parties Notes Payable 8 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 1,050
Related Parties Notes Payable 9 [Member]
Interest Rate		12.00%
Related Parties Notes Payable			$ 130,000
Principal amount		$ 130,000
Maturity Date		Mar. 31, 2020
Stock issued for conversion of debt, shares		182,525
Related Parties Notes Payable 9 [Member] | Principal
Stock issued for conversion of debt		$ 130,000
Related Parties Notes Payable 9 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 9,078

Notes Payable, Related Party _5

Notes Payable, Related Party Notes Payable, Convertible Bridge Loans Payable, Revenue Financing Arrangements (Details 2) - USD ($)	1 Months Ended	9 Months Ended
	Mar. 27, 2020	Sep. 30, 2020	Dec. 31, 2019
Interest Rate	1.00%
Convertible Bridge Loans Payable		$ 100,000	$ 2,202,664
Principal amount	$ 158,000
Convertible Bridge Loans Payable 1 [Member]
Interest Rate		4.00%
Convertible Bridge Loans Payable		$ 100,000	100,000
Principal amount		$ 100,000
Convertible Bridge Loans Payable 2 [Member]
Interest Rate		12.00%
Convertible Bridge Loans Payable			39,388
Principal amount		$ 39,388
Stock issued for conversion of debt, shares		59,694
Convertible Bridge Loans Payable 2 [Member] | Principal
Stock issued for conversion of debt		$ 39,388
Convertible Bridge Loans Payable 2 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 5,973
Convertible Bridge Loans Payable 3 [Member]
Interest Rate		12.00%
Convertible Bridge Loans Payable			164,307
Principal amount		$ 164,307
Stock issued for conversion of debt, shares		249,013
Convertible Bridge Loans Payable 3 [Member] | Principal
Stock issued for conversion of debt		$ 164,307
Convertible Bridge Loans Payable 3 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 24,916
Convertible Bridge Loans Payable 4 [Member]
Interest Rate		12.00%
Convertible Bridge Loans Payable			391,361
Principal amount		$ 391,361
Maturity Date		Aug. 26, 2020
Stock issued for conversion of debt, shares		435,184
Convertible Bridge Loans Payable 4 [Member] | Principal
Stock issued for conversion of debt		$ 391,361
Convertible Bridge Loans Payable 4 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 43,823
Convertible Bridge Loans Payable 5 [Member]
Interest Rate		9.00%
Convertible Bridge Loans Payable			20,000
Principal amount		$ 20,000
Stock issued for conversion of debt, shares		41,336
Convertible Bridge Loans Payable 5 [Member] | Principal
Stock issued for conversion of debt		$ 20,000
Convertible Bridge Loans Payable 5 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 10,096
Convertible Bridge Loans Payable 6 [Member]
Interest Rate		12.00%
Convertible Bridge Loans Payable			795,137
Principal amount		$ 795,137
Maturity Date		Aug. 26, 2020
Stock issued for conversion of debt, shares		884,174
Convertible Bridge Loans Payable 6 [Member] | Principal
Stock issued for conversion of debt		$ 795,137
Convertible Bridge Loans Payable 6 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 89,037
Convertible Bridge Loans Payable 7 [Member]
Interest Rate		12.00%
Convertible Bridge Loans Payable			$ 692,471
Principal amount		$ 692,471
Maturity Date		Aug. 26, 2020
Stock issued for conversion of debt, shares		770,012
Convertible Bridge Loans Payable 7 [Member] | Principal
Stock issued for conversion of debt		$ 692,471
Convertible Bridge Loans Payable 7 [Member] | Unpaid Accrued Interest
Stock issued for conversion of debt		$ 77,541

Notes Payable, Related Party _6

Notes Payable, Related Party Notes Payable, Convertible Bridge Loans Payable, Revenue Financing Arrangements (Details 3) - USD ($)	1 Months Ended	9 Months Ended	12 Months Ended
	Mar. 27, 2020	Sep. 30, 2020	Dec. 31, 2016	Dec. 31, 2019
Interest Rate	1.00%
Revenue Financing Arrangements		$ 45,467		$ 45,467
Principal amount	$ 158,000
Revenue Financing Arrangements 1 [Member]
Interest Rate		10.00%
Revenue Financing Arrangements		$ 28,032		28,032
Principal amount		50,000	$ 57,000
Daily payments		$ 999
Revenue Financing Arrangements 2 [Member]
Interest Rate		12.00%
Revenue Financing Arrangements		$ 17,435		$ 17,435
Principal amount		55,000
Daily payments		$ 1,299
Revenue Financing Arrangements First [Member]
Principal amount			60,000
Daily payments			928
Revenue Financing Arrangements Second [Member]
Daily payments			$ 713

Notes Payable, Related Party _7

Notes Payable, Related Party Notes Payable, Revenue Financing Arrangements (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Accrued interest	$ 421,952		$ 421,952		$ 1,604,498
Notes Payables [Member]
Interest expense	3,377	$ 28,813	73,236	$ 86,439
Accrued interest	258,738		258,738		581,693
Related Parties Notes Payable [Member]
Interest expense	0	24,714	37,967	74,342
Accrued interest	0		0		546,362
Convertible Bridge Loans Payable [Member]
Interest expense	8,000	$ 70,480	109,785	140,960
Accrued interest	163,215		163,215
Revenue Financing Arrangements [Member]
Interest expense			25,067	$ 1,723
Accrued interest	0		0		32,154
Bridge Loan Payable [Member]
Interest expense			0
Accrued interest	$ 0		$ 0		$ 439,344

Licensing Agreement and Royal_2

Licensing Agreement and Royalty Payable (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Notes to Financial Statements
Payment for Licensing			$ 45,000	$ 39,000
Minimum royalty payments	$ 135,000	$ 117,000	405,000	$ 351,000
Unpaid amount of royalties					$ 39,000

Deficiency in Stockholders' E_2

Deficiency in Stockholders' Equity (Details Narrative) - USD ($)	1 Months Ended		9 Months Ended	12 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Sep. 30, 2020	Dec. 31, 2019
Stock issued in exchange for services, shares				1,846,078
Share Price			$ 0.73	$ 0.73
Stock issued in exchange for services, value				$ 1,354,500
Warrant term			3 years
Treasury stock repurchased			1,226,630
Treasury stock retired			817,753
Stock held in treasury			408,877
Treasury Stock issued	136,292	136,292
Warrant issued			975,000
Stock Price			$ 0.25
Sale of common stock			300,000
Common stock issued for exercise of warrants			975,000
Stock issued			490,652
Multiple Subscription Agreements [Member]
Stock issued in exchange for services, shares			3,429,601
Stock issued in exchange for services, value			$ 3,391,683
Private Placement Memorandum [Member]
Sale of stock in private placement			2,790,909
Share price			$ 1.10
Proceeds from private placement			$ 3,070,000
Series A Convertible Preferred Stock [Member]
Warrant term			5 years
Warrant issued			4,088,765
Stock Price			$ .73
Series A Convertible Preferred Stock [Member] | SBG [Member]
Warrant term			3 years
Warrant issued			1,000,000
Stock Price			$ 0.18
Warrants exchanged			1,362,922
Series B Convertible Preferred Stock [Member]
Warrant term			5 years
Warrant issued			5,333,675
Stock Price			$ 1.10
Warrants Outstanding			935,386

Share-Based Payments (Details)

Share-Based Payments (Details)	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Share-based Payment Arrangement [Abstract]
Stock options outstanding, beginning balance | shares	1,124,410
Stock options Granted | shares
Stock options exercised | shares
Stock options Cancelled/forfeited | shares
Stock options outstanding, ending balance | shares	1,124,410
Stock options exercisable | shares	1,124,410
Weighted average exercise price, outstanding | $ / shares	$ 0.77
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, Cancelled/forfeited | $ / shares
Weighted average exercise price, outstanding | $ / shares	0.77
Weighted average exercise price, exercisable | $ / shares	0.77
Weighted average grant date fair value of options during year | $ / shares
Weighted average duration to expiration of outstanding options	4 years 3 months 19 days

Share-Based Payments (Details N

Share-Based Payments (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Stock price	$ 0.73		$ 0.73
Warrants term	3 years
Number of option exercised
Stock based compensation expense	$ 2,329,280	$ 532,276
Stock Plan
Stock price	$ 0.12
Reserved shares for issuance under the Plan	4,088,765
Grant term	10 years
Number of option exercised	2,657,698
Proceeds from Stock Options Exercised	$ 312,000
Options issued and outstanding	1,124,410
Number of options available for grant	306,657
Stock based compensation expense			$ 265,589
Unrecognized compensation cost	$ 0
GMA
Warrant Issued for consulting Services	1,362,922
Common stock price	$ 0.007
Weighted average life of outstanding warrants			3 years 9 months
Exercise price	$ 0.008
Warrant retired	1,362,922
Warrant pre-merger issued	2,725,844
Stock price	$ 0.18
Warrants term	3 years
Employees And Consultants
Option granted	1,124,410

Related Parties (Details Narrat

Related Parties (Details Narrative) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Related party payables		$ 1,505,100
WesBev
Related party payables	50,000
Chief Executive Officer [Member]
Related party payables	$ 469,904

Investment in Salt Tequila US_2

Investment in Salt Tequila USA, LLC (Details Narrative) - Salt [Member]	9 Months Ended
	Sep. 30, 2020
Ownership interest	15.00%
Equity stake percentage	37.50%
Stock sale description	The agreement is for $1,000,000 to be paid in 4 tranches of $250,000 and entitles us to additional equity interest in Salt Tequila USA, LLC as follows: • Tranche 1 – 7.5% • Tranche 2 – 5.0% • Tranche 3 – 5.0% • Tranche 4 – 5.0%

Operating Lease Obligations (De

Operating Lease Obligations (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Notes to Financial Statements
2020	$ 22,172
2021	59,291
Thereafter	25,910
Total	107,372
Amount representing imputed interest	(4,136)
Total operating lease liability	103,237
Current portion of operating lease liability	70,297	$ 81,502
Operating lease liability, non-current	$ 32,940	$ 82,238

Operating Lease Obligations (_2

Operating Lease Obligations (Details 1)	9 Months Ended
	Sep. 30, 2020USD ($)
Operating lease cost:
Amortization of leased assets	$ 114,032
Interest of lease liabilities	10,776
Total operating lease cost	$ 124,808

Operating Lease Obligations (_3

Operating Lease Obligations (Details 2)	Sep. 30, 2020
Incremented borrowing rate	5.00%
Minimum [Member]
Remaining term on leases	9 months
Maximum [Member]
Remaining term on leases	25 months

Operating Lease Obligations (_4

Operating Lease Obligations (Details Narrative)	9 Months Ended
	Sep. 30, 2020
First Lease [Member]
Lease commencement date	Jul. 1, 2018
Lease expiration date	Jun. 30, 2021
Operating lease term	36 months
Second Lease [Member]
Lease commencement date	Nov. 1, 2014
Lease expiration date	Mar. 31, 2020
Operating lease term	62 months
Lease termination date	Feb. 28, 2018
Third Lease [Member]
Lease commencement date	Nov. 1, 2019
Lease expiration date	Apr. 30, 2020
Operating lease term	6 months
Fourth Lease [Member]
Lease commencement date	Nov. 11, 2019
Lease expiration date	Nov. 11, 2020
Fifth Lease [Member]
Lease commencement date	May 1, 2019
Lease expiration date	Apr. 1, 2021
Operating lease term	24 months

Line of Credit (Details Narrati

Line of Credit (Details Narrative)	3 Months Ended	9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2020USD ($)
Debt Disclosure [Abstract]
Line of credit	$ 68,000	$ 68,000
Interest rate		6.10%
Interest expense	$ 300	$ 2,300

PPP Loan (Details Narrative)

PPP Loan (Details Narrative)	1 Months Ended
	Mar. 27, 2020USD ($)
Notes to Financial Statements
Principal balance	$ 158,000
Interest rate	1.00%
Term	18 months

Business Combinations (Details)

Business Combinations (Details)	Sep. 30, 2020USD ($)
Business Combinations [Abstract]
Cash and cash equivalents	$ 72,442
Accounts receivable	311,586
Inventory	21,415
Property and equipment	38,110
Goodwill	9,448,832
Accounts payable, accrued expenses and other liabilities	719,221
Purchase price	$ 9,173,164

Business Combinations (Details

Business Combinations (Details Narrative)	9 Months Ended
	Sep. 30, 2020USD ($)
Business Combinations [Abstract]
Purchase price	$ 9,200,000

Segment Reporting (Details)

Segment Reporting (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Total Revenues	$ 1,009,615		$ 1,733,926	$ 47,086
Total assets	13,036,937		13,036,937		$ 605,314
Splash Beverage Group [Member]
Total Revenues	91,778		213,174	14,445
Total assets	2,725,853		2,725,853		446,288
B2C Business [Member]
Total Revenues	601,196		1,004,536	32,641
Total assets	435,933		435,933		159,026
Medical Devices [Member]
Total Revenues	316,641		516,217
Total assets	$ 9,875,151		$ 9,875,151

Commitment and Contingencies (D

Commitment and Contingencies (Details Narrative)	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Capital Raise Description	In connection with the merger we are committed to our previous preferred stock and debt holders to raise $9 million in a secondary IPO, private placement and debt as defined in the agreements. There cannot be any assurance that we will raise this capital as required.

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2019
Stock issued in exchange for services, shares			1,846,078
Share Price		$ 0.73	$ 0.73
Stock issued in exchange for services, value			$ 1,354,500
Multiple Subscription Agreements [Member]
Stock issued in exchange for services, shares		3,429,601
Stock issued in exchange for services, value		$ 3,391,683
Multiple Subscription Agreements [Member] | Subsequent Event [Member]
Stock issued in exchange for services, shares	1,895,000
Share Price	$ 1.10
Stock issued in exchange for services, value	$ 1,722,727
Warrants Purchased	861,361